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The adapter protein 3BP2 is expressed in lymphocytes; binds to Syk/ZAP-70, Vav, and phospholipase C-
(PLC-); and is thought to be important for interleukin-2 gene transcription in T cells. To define the role of
3BP2 in lymphocyte development and function, we generated 3BP2-deficient mice. T-cell development, prolif-
eration, cytokine secretion, and signaling in response to T-cell receptor (TCR) ligation were all normal in
3BP2/ mice. 3BP2/ mice had increased accumulation of pre-B cells in the bone marrow and a block in the
progression of transitional B cells in the spleen from the T1 to the T2 stage, but normal numbers of mature
B cells. B-cell proliferation, cell cycle progression, PLC-2 phosphorylation, calcium mobilization, NF-ATp
dephosphorylation, and Erk and Jnk activation in response to B-cell receptor (BCR) ligation were all impaired.
These results suggest that 3BP2 is important for BCR, but not for TCR signaling.
3BP2 is a protein originally characterized as an Abl SH3-
interacting protein (44). It consists of an N-terminal pleckstrin
homology domain, a proline-rich central region, and a C-ter-
minal SH2 domain. 3BP2 mRNA is expressed in hematopoi-
etic tissues. 3BP2 protein is expressed in T cells, B cells, natural
killer (NK) cells, monocytic cell lines, osteoclasts, and the rat
basophilic leukemia cell line RBL-2H3 (11, 37). 3BP2 associ-
ates with Syk and ZAP-70 (11, 36). Association of 3BP2 with
Syk was shown to require the SH2 domain of 3BP2 and the
catalytic activity of Syk. The SH2 domain of 3BP2 has also
been shown to bind to the adapter protein LAT in T cells
and mast cells after T-cell receptor (TCR) and FcεRI liga-
tion, respectively (11, 46). Phospholipase C- (PLC-) and
Vav were also identified as binding partners of 3BP2 (22).
Other partners of 3BP2 include 14-3-3, Grb2, Cbl, and Fyn
(11, 14, 15).
TCR stimulation induces a significant translocation of 3BP2
to the membrane and detergent-insoluble (cytoskeleton) frac-
tions, suggesting a role for 3BP2 in TCR-mediated signal trans-
duction (11). Transient overexpression of 3BP2 in Jurkat T
cells induces transcriptional activation of the interleukin-2
(IL-2) gene promoter and its NF-AT and AP-1 elements and
cooperates with TCR ligation and ionomycin in activating NF-
AT/AP-1-driven transcription. Overexpression of 3BP2 re-
sulted in calcineurin-dependent dephosphorylation of NF-ATc
and stimulated AP-1 activity independently of NF-AT (11).
The SH2 and PH domains of 3BP2, but not its proline-rich
domain, are required for NF-AT activation. Furthermore,
overexpression of the SH2 domain of 3BP2 inhibited TCR-
mediated NF-AT activation (11). Activation of NF-AT by
3BP2 in T cells required ZAP-70, because overexpression of
3BP2 in a ZAP-70-deficient Jurkat cell clone failed to activate
NF-AT (11).
Overexpression of 3BP2 enhances NK cell-mediated cyto-
toxicity (22). FcεRI ligation induces the phosphorylation of
3BP2 and its association with LAT in rat basophilic leukemia
RBL-2H3 cells (46). Overexpression of the SH2 domain of
3BP2 in these cells suppresses FcεRI-induced signaling (46).
Recently, it was shown that 3BP2 is tyrosine phosphorylated
following B-cell receptor (BCR) ligation in B cells and is a
substrate for Syk and Fyn, but not Btk (14). 3BP2 was shown to
interact with several components of the BCR signaling path-
way, including Syk, PLC-, and Vav, and cooperated with Vav
to activate NF-AT after BCR ligation. To investigate the role
of 3BP2 in lymphocyte development and function, we gener-
ated 3BP2-null mice by gene targeting.
MATERIALS AND METHODS
Generation of 3BP2-deficient mice. The 3bp2 gene was cloned from isogenic
129 genomic DNA library (Stratagene) using the full-length cDNA as a probe.
The 5 5.4-kb arm (PstI-EcoRV) and the 3 8-kb arm (HindIII-HindIII) frag-
ments were subcloned into pScrambler vector (Stratagene), which contains the
neomycin phosphotransferase (neo) cDNA driven by the PGK promoter. The
construct was introduced by electroporation into embryonic stem (ES) cells using
standard protocols (2), and cells were then selected in medium containing 200
g/ml G418 and 1 M ganciclovir. ES clones containing the homologous recom-
binant event were identified by Southern blot analysis and by a 5.6-kb PCR
product using forward primer a (5-TGAGTCACTGGATCATGGGAG-3) lo-
cated upstream of the 5 arm and reverse primer b (5-CGCATGCTCCAGAC
TGCCTTG-3) located in the neo gene. A 0.3-kb product is amplified by PCR
from the WT allele using forward primer c in exon 9 (5-ACAGGCTGACACT
GGCGA-3) and reverse primer d in exon 10 (5-CGCAAGACTCTGTCGTG
T-3). Two ES clones (no. 3 and 7) with the recombinant allele were injected in
C57BL/6 blastocysts, and 3BP2/ mice were obtained by standard methods
(54). 3BP2 mRNA expression was analyzed by reverse transcription-PCR (RT-
PCR) using a forward primer, e, that hybridizes to exon 2 (5GCTGGTTACC
TGCATAAG3) and a reverse primer, f, that hybridizes to the 5 half of exon 6
(5ATAGGTCGCTCAACTGCA3). 3BP2 protein expression was examined by
Western blotting using an antibody raised against amino acids 359 to 462 of the
protein.
FACS analysis. Single-cell suspensions from spleen, bone marrow, thymus,
and peritoneal cavity were isolated on a density gradient of Lympholyte-M
(Cedarlane Laboratories). Cells were stained with phycoerythrin- or fluorescein
isothiocyanate (FITC)-labeled monoclonal antibodies (MAbs) from PharMingen
and analyzed on a FACSCalibur flow cytometer (Becton Dickinson) as previ-
ously described (2). Fluorescence-activated cell sorter (FACS) analysis was per-
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formed on cells from mice between 6 and 10 weeks of age. Annexin-FITC
staining and propidium iodide (PI) staining were performed using a kit from
Biovision Inc.
Antibodies. The MAbs were obtained from the following suppliers: anti-CD3ε
(KT3) was from Serotec, anti-CD28 was from eBioscience, antiactin was from
Chemicon, anti-ZAP-70 and anti-PY 4G10 were from UpstateBiotechnology,
and anti-CD40 was from R&D. The polyclonal antibodies were obtained from
the following suppliers: anti-Syk was from Abcam; anti-Vav1, -PLC-1, and
-PLC-2 were from Santa Cruz Biotechnology; anti-NF-ATp was a gift from A.
Rao; anti-cyclin D2 was from Biosource; and anti-cyclin D3, -cdk4, -cdk6, -p27,
and -pRb antibodies were from Cell Signaling. All antibodies to mitogen-acti-
vated protein (MAP) kinases were from Cell Signaling, except antibody to
phospho-Jnk, which was from Biosource.
Cell purification, proliferation of splenic T and B cells, and Ig synthesis.
Splenic T cells were purified (95% CD3 cells) by negative selection using
CD3 enrichment columns (R&D) and cultured at 1  105/well for 64 h in wells
coated with 2 g/ml anti-CD3 MAb, with or without 2 g/ml anti-CD28 MAb or
IL-2 (R&D Systems) at 40 ng/ml. Phorbol myristate acetate was used at 15 ng/ml,
and ionomycin was used at 0.5 M. Proliferation was assessed by the incorpo-
ration of [3H]thymidine. Concentrations of IL-2 in supernatants were measured
by enzyme-linked immunosorbent assay (ELISA; R&D). B cells were purified
from splenocytes labeled with biotin-conjugated MAbs to CD43 and CD11b (BD
Pharmingen) and negatively sorted with streptavidin-conjugated magnetic beads
(Dynal). B cells (85% CD43-negative cells) were cultured at 1  105/well in
medium alone or in the presence of goat F(ab)2 anti-mouse immunoglobulin M
(IgM) (Jackson Immunoresearch) without or with IL-4 (40 ng/ml; R&D Sys-
tems), anti-CD40 (2 g/ml; R&D), or lipopolysaccharide (LPS; 10 g/ml
[Sigma]), and 48 h later, the cells were pulsed with 1 Ci [3H]thymidine and
counted. B and T cells were also incubated with 5 M 5,6-carboxyfluorescein
succinimidyl ester (CFSE) at 37°C for 10 min and then washed in phosphate-
buffered saline (PBS) before culture at 37°C with different stimuli. After 72 h,
cells were analyzed by FACS and percentages of cells for each cell division were
calculated. For Ig synthesis, B cells were cultured in complete medium alone or
in the presence of 10 g/ml LPS (Sigma-Aldrich) and IL-4 without or with goat
F(ab)2 anti-mouse IgM as previously described (21). After 6 days, supernatants
were assayed for IgM, IgG1, and IgE by ELISA.
For in vitro survival, purified B cells were cultured at 5  105 cells/ml in the
presence or absence of 200 and 500 ng/ml BAFF (Biosource). At various time
points, viable cells were counted in a light microscope using a Neubauer hemo-
cytometer and the trypan blue exclusion test. B cells were also washed, incubated
with 10 g/ml merocyanine 540 (Sigma-Aldrich) in PBS–0.1% bovine serum
albumin, and analyzed by FACS.
Immunoprecipitation and Western blotting. Cells were lysed in ice-cold lysis
buffer containing 1% Triton X-100, and lysates were centrifuged for 15 min at
4°C and precleared for 1 h at 4°C with protein G-Sepharose (Amersham Phar-
macia Biotech). Immunoprecipitation was performed overnight at 4°C with
antibody preadsorbed onto protein G-Sepharose. Beads were washed five times
with modified lysis buffer containing 0.2% Triton X-100. Bound proteins were
eluted, run on sodium dodecyl sulfate-polyacrylamide gel electrophoresis, and
analyzed by Western blotting with the indicated antibodies followed by goat
anti-mouse or rabbit antibodies conjugated to horseradish peroxidase (Amer-
sham) and enhanced chemiluminescent (ECL) detection (Perkin-Elmer). As
indicated, Western blot images were scanned and quantified using NIH Image
(version 1.63) software.
Calcium mobilization. Measurement of calcium flux was done as described
previously (30). Briefly, 2  106 purified T or B cells/ml were incubated with 4
g/ml Fluo-4-AM (Molecular Probes). T cells were preloaded with 2 g/ml
anti-CD3 antibody and then stimulated with 10 g/ml goat F(ab)2 anti-rat IgG.
B cells were stimulated with 5 to 20 g/ml goat F(ab)2 anti-mouse IgM. Cells
were analyzed by FACS. Intracellular Ca2 concentration was measured by
FACS as Fluo-4AM fluorescence intensity using the FL1 channel.
Serum Ig levels and antibody responses. Serum Ig levels were quantified by
ELISA. Immunizations with keyhole limpet hemocyanin (KLH), 2,4,6-trinitrophenyl
(TNP)–LPS, and TNP-Ficoll were performed, and the serum antibody responses to
KLH and TNP were determined by ELISA as previously described (54).
Statistical analysis. Statistical analysis of the data using Student’s t test was
performed with Prism software.
RESULTS
Generation of 3BP2/mice. A targeting construct, in which
the 3 half of exon 6 plus all of exons 7 through 13 of murine
3bp2 were replaced with a neomycin-resistant gene, was intro-
duced into ES cells (Fig. 1A). The deletion includes the pro-
line-rich region and the SH2 domain of 3BP2. ES clones with
targeted disruption of 3bp2 were identified by Southern blot-
ting and genomic PCR (data not shown). Of 250 ES clones
analyzed, 5 were found to have a disrupted allele and 2 were
used to generate 3BP2/ mice. Mice with a disrupted 3bp2
gene were identified by PCR on tail genomic DNA, as evi-
denced by the amplification of a novel 5.6-kb fragment derived
from the targeted allele compared to the 0.3-kb fragment de-
rived from the WT allele (Fig. 1B). Lysates and immunopre-
cipitates from thymus and spleen probed by Western blotting
using an antibody raised against an amino acid sequence im-
mediately upstream of the SH2 domain of 3BP2 (amino acids
359 to 462) revealed no detectable 3BP2 protein in 3BP2/
mice (Fig. 1C) (data not shown). Because there are no avail-
able antibodies directed against the N-terminal region of
3BP2, we looked for the presence of a transcript encoded by
the N-terminal exons preserved in the targeted allele. RT-PCR
analysis of mRNA from splenocytes with primers that hybrid-
ize to sequences in exon 2 and exon 6, which are preserved in
the targeted allele, amplified a 392-bp product in WT mice, but
no detectable product in 3BP2/ mice (Fig. 1D). 3BP2/
mice did not display apparent differences from WT littermates
in growth, weight, or health. Results of all analyses presented
below were similar in the two independently derived 3BP2/
mouse strains.
Lymphoid development in 3BP2/ mice. Cellularity of the
thymus, bone marrow, spleen, and peritoneum was normal in
3BP2/ mice. Detailed FACS analysis of thymocytes from
3BP2/ mice and WT littermates at 6 to 10 weeks of age
revealed no obvious difference in the percentages of CD4 and
CD8 cells or of CD3, TCR-	, TCR-
, and CD2 cells
(data not shown). Bone marrow cells from 3BP2/ mice had
a normal percentage of the B220 CD43 pro-B-cell popula-
tion (Fig. 2A, upper panel), but an increased percentage of
B220lo IgM population (Fig. 2A, lower panel) that includes
pro-B cells and pre-B cells, indicating that pre-B cells were
increased (approximately twofold). The percentages of B220lo
IgM immature B cells (Fig. 2A, lower panel) and B220hi
IgM/B220hi CD43 mature recirculating B cells (Fig. 2A,
upper and lower panels) were normal. The absolute numbers
of pro-B, pre-B, immature, and recirculating B cells in bone
marrow from femurs of 3BP2/ mice and WT controls were
determined using triple staining for IgM, B220, and CD43. The
results revealed a significant increase in the numbers of pre-B
cells in 3BP2/ mice and no significant difference in the
numbers of the other B-cell populations (Table 1). There were
no obvious differences in the numbers and percentages of
Thy1 CD4, CD8, B220 IgM, and IgD cells in spleens
and lymph nodes of 3BP2/ mice and WT littermates (Fig.
2B) (data not shown).
Immature IgMhi HSA/CD24 bone marrow B cells are
transported into the spleen, where they start to express the
complement receptor CD21, a part of the CD19-CD21-CD81
coreceptor complex, and the low-affinity IgE receptor CD23.
Splenic transitional B cells have been divided into IgM CD24hi
CD21 CD23 T1 cells, which mature into IgMhi CD21 CD23
T2 cells (8). T2 cells mature into IgMlo CD21 CD23 follicular
B cells, which recirculate. Marginal zone (MZ) B cells are a
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sessile population of IgM CD21 CD23 cells generated
from T2 cells and possibly from follicular B cells and are
located close to the marginal sinus. MZ B cells play an impor-
tant role in the response to TI antigens (1, 7). Detailed analysis
of spleen B cells was performed by simultaneously staining for
IgM, CD21, and CD24 or IgM, CD21, and CD23 (Fig. 2C).
3BP2/ mice had an increased percentage of IgM CD24hi
CD23 transitional T1 cells (17.2%  3.2% of splenic B cells
in 3BP2/ mice versus 11.4%  1.3% in controls; P  0.05,
n  3), a decreased percentage of IgMhi CD21 CD23 T2
cells (5.3%  2.0% of splenic B cells in 3BP2/ mice versus
12.4%  3.3% in controls; P  0.05, n  3), and a normal
percentage of IgMlo CD21 CD23 follicular B (FO) cells
(66.5%  10.7% of splenic B cells in 3BP2/ mice versus
68.7%  8.4% in controls; n  3). There was no significant
difference in the percentage of IgM CD21 CD23 MZ B
cells (3.7%  2% in 3BP2/ mice versus 4.2%  1.3% in
controls; n  5). There was a significant decrease of CD23
expression on IgM splenic B cells from 3BP2/ mice (mean
fluorescence intensity [MFI], 222  76.4 in 3BP2/ mice
versus 773  268.4 in controls; P  0.0001, n  9). A similar
decrease in CD23 expression was observed on peripheral blood
B cells (data not shown). The percentage of IgM CD5 B1
cells in the peritoneum of 3BP2/ mice was normal (Fig. 2D).
These results suggest that 3BP2 plays a role in the progression
from pre-B cells to immature B cells and from T1 to T2 B cells.
Normal T-cell function in 3BP2/ mice. The proliferation
of T cells from 3BP2/ mice in response to plates coated with
anti-CD3 was similar to that of T cells from WT littermates
over the range of anti-CD3 concentrations tested (0.3 to 10
g/ml) (Fig. 3A). Similar proliferation of 3BP2/ and WT T
cells was also observed when cells were stimulated with anti-
CD3 plus anti-CD28 or anti-CD3 plus IL-2 (Fig. 3B). Consis-
tent with the results from [3H]thymidine incorporation, similar
percentages of T cells from 3BP2/ mice and WT controls
underwent a comparable number of rounds of cell division in
response to anti-CD3, with or without anti-CD28, as deter-
mined by CFSE dilution assay (Fig. 3C). 3BP2/ T cells
normally upregulated CD69 and CD25 surface expression fol-
lowing TCR ligation (data not shown) and secreted normal
amounts of IL-2 following stimulation with anti-CD3 plus anti-
CD28 (Fig. 3D). These results suggest that 3BP2 is not essen-
tial for T-cell activation in response to TCR ligation.
TCR signaling is normal in 3BP2/ mice. TCR ligation
results in protein tyrosine phosphorylation that includes phos-
phorylation of ZAP-70, Vav, and PLC-1. Total protein ty-
rosine phosphorylation and phosphorylation of ZAP-70, Vav,
and PLC-1 were normal in 3BP2/ T cells (Fig. 4A and B).
PLC-1 activation results in IP3 generation and calcium mo-
bilization. Calcium mobilization after TCR ligation was normal
in T cells from 3BP2/ mice (Fig. 4C). Phosphorylation of the
FIG. 1. Generation of 3BP2-deficient mice (A). Genomic structure of the murine 3bp2 gene, targeting vector, and predicted structure of the
targeted allele after homologous recombination. Exons are represented by boxes. Neo, neomycin resistance gene; TK, thymidine kinase gene.
(B) PCR analysis of tail genomic DNA from 3BP2/, 3BP2/, and 3BP2/ littermates. Two sets of primers were used in the same reaction and
are shown in Fig. 1A. Primers a and b amplify a 5.6-kb band in the rearranged allele. Primers c and d amplify a 0.3-kb band in the WT allele.
(C) Western blot (WB) analysis of 3BP2 immunoprecipitates from thymocytes of two 3BP2/ mice (knockout [KO] mice 3 and 7) derived from
different founders and a WT control (PS, preimmune rabbit serum). (D) RT-PCR analysis of mRNA from splenocytes of WT and 3BP2/ mice
using primers e and f, which hybridize to exon 2 and the 5 region of exon 6 that is preserved in the targeted allele. These two primers amplify
a 392-bp product from cDNA. GAPDH (glyceraldehyde-3-phosphate dehydrogenase) is used as a positive control.
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MAP kinases Erk, Jnk, and p38 was also normal in these cells
(Fig. 4D).
Impaired B-cell proliferation in response to BCR ligation in
3BP2/ mice. Primary mouse splenic B cells express 3BP2
(data not shown). Highly purified B cells (90% B220) from
3BP2/ mice showed a significant defect in proliferation in
response to BCR cross-linking with anti-IgM over the range of
concentrations tested (0.8 to 12 g/ml), as assessed by [3H]thy-
midine incorporation (P  0.05, n  6) (Fig. 5A). This defect
was partially corrected by IL-4, although the proliferation of B
cells from 3BP2/ mice to anti-IgM plus IL-4 remained sig-
nificantly lower than that of WT B cells (Fig. 5B). Consistent
with results from [3H]thymidine incorporation, CFSE dilu-
tion assays showed that after anti IgM treatment a lower
percentage of B cells from 3BP2/ mice entered cell divi-
sion compared to WT B cells (Fig. 5C, middle panel). Cell
division was also delayed in 3BP2/ B cells treated with
anti-IgM plus IL-4 (Fig. 5C, right panel). 3BP2/ B cells
proliferated normally in response to anti-CD40  IL-4 and
LPS  IL-4, as determined by [3H]thymidine incorporation
(Fig. 5D) and CFSE dilution assay (data not shown).
3BP2/ B cells normally upregulated surface expression of
the major histocompatibility complex class II and CD86 in
response to all stimuli tested, including anti-IgM (data not
shown).
Normal B-cell survival in response to BCR ligation, but
impaired expression of cell cycle regulatory proteins in B cells
in 3BP2/ mice. To determine whether the impaired B-cell
FIG. 2. Detailed FACS analysis of B cells in bone marrow (A), spleen (B and C), and peritoneum (D). In panel C, T1 cells were identified as
CD24hi CD21 cells in the IgM gate (top panel), T2 cells as IgMhi CD21 cells in the IgM/CD23 gate (middle panel), and follicular B cells as CD24
CD21cells in the IgM gate (top panel) and as IgMlo CD21 in the CD23 gate (middle panel). MZ B cells were identified as CD21 CD23
cells in the IgM gate (lower panel). The percentages shown in the middle panel were adjusted to depict the percentage of total IgM cells. KO,
knockout.
TABLE 1. Absolute numbers of B lineage cells in bone marrow
Mouse
genotype
No. of B lineage cells (106)a
Total
B220lo
CD43
(pro-B)
B220lo
CD43
IgM
(pre-B)
B220lo
CD43
IgM
(immature)
B220hi IgM
(recirculating)
WT 15.51  1.21 0.37  0.03 0.63  0.08 0.44  0.07 0.30  0.02
3BP2/ 17.62  1.81 0.49  0.05 1.56  0.11* 0.38  0.06 0.35  0.04
a The means  standard deviation of the absolute numbers are shown for the
indicated populations in one femur each from WT and 3BP2/ mice (n  6
each). *, P  0.05.
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proliferation in response to anti-IgM was due to impaired
survival, we performed dual staining with annexin V and PI.
We found no difference in the percentage of annexin V apop-
totic cells and annexin V/PI necrotic cells between B cells
from 3BP2/ mice and WT littermates at 24 h and 48 h
poststimulation with anti-IgM  IL-4 or LPS (Fig. 6A). These
results suggest that 3BP2 is not essential for the survival of B
cells following BCR ligation.
Cyclins and cyclin-dependent kinases (Cdks) as well as Cdk
inhibitors control cycle progression. With entry into the cell
cycle, the levels of cyclins D2 and D3 and of their partners
Cdk4 and Cdk6 are upregulated, the level of the Cdk inhibitor
p27 decreases, and the Cdk target retinoblastoma tumor sup-
pressor protein Rb is phosphorylated on Ser807 and Ser811 (5,
32, 51). We examined these events in WT and 3BP2/ B cells
stimulated with anti-IgM. Stimulation of WT B cells with
anti-IgM resulted in upregulation of the levels of cyclins D2
and D3 and of their partners Cdk4 and Cdk6, decreased p27
levels, and Rb phosphorylation (Fig. 6B). 3BP2/ B cells
exhibited defective upregulation of cyclins D2 and D3,
Cdk4, and, to a lesser extent, Cdk6; no detectable decrease
in p27 levels; and no detectable Rb phosphorylation after
stimulation with anti-IgM (Fig. 6B). These defects were
partially rescued by IL-4. 3BP2/ B cells responded nor-
mally to LPS. Taken together, these results suggest that
3BP2 is important for the progression of B cells through the
cell cycle following BCR ligation.
BAFF is important for B-cell survival (45). We examined the
survival response of B cells from 3BP2/ mice to BAFF (200
ng/ml and 500 ng/ml). Cells were analyzed every 24 h by trypan
blue exclusion for 5 days. No significant difference in the per-
centages of viable cells was found between WT and 3BP2/
mice (n  4 each) at any time point. At 5 days, the viability of
WT B cells was 4%  2% in medium versus 41%  5% in 200
ng/ml BAFF. At that time point, the viability of 3BP2-deficient
B cells was 6%  2% in medium versus 38%  6% in BAFF
(data not shown). Similar results were obtained when the cells
were analyzed by FACS for exclusion of merocyanine 540 (data
not shown).
Impaired BCR signaling in 3BP2/ mice. 3BP2 has been
shown to associate with Syk, Vav, and PLC-2, which are
phosphorylated and activated following BCR ligation (11, 14).
There was no detectable decrease in the tyrosine phosphory-
lation of Syk and Vav1 after BCR ligation in 3BP2/ B cells
(Fig. 7A). In contrast, PLC-2 phosphorylation was decreased
(Fig. 7A). Calcium mobilization after BCR ligation was im-
paired in B cells from 3BP2/ mice over several concentra-
tions of anti-IgM (5, 10, 15, and 20 g/ml) tested (Fig. 7B)
FIG. 3. T-cell proliferation and cytokine secretion in 3BP2/ mice. (A and B) Proliferation of purified T cells from 6- to 10-week-old WT mice
and 3BP2/ littermates (knockout [KO] mice) to increasing concentrations of anti-CD3 (-CD3) used to coat wells (A) and to anti-CD3 (2 g/ml)
with or without soluble anti-CD28 (-CD28; 2 g/ml) or IL-2 (40 ng/ml), and to phorbol myristate acetate and ionomycin (PIo) (B), as assessed
by [3H]thymidine incorporation. Med, medium. (C) Proliferation of purified T cells to anti-CD3  anti-CD28 as assessed by CFSE dilution assay.
(D) Secretion of IL-2 in supernatants. Results shown are representative of three experiments.
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(data not shown), suggesting impaired activation of PLC-2. B
cells from 3BP2/ mice responded with normal calcium influx
to ionomycin.
Calcium mobilization plays a critical role in calcineurin-
dependent dephosphorylation of the transcription factor NF-
ATp, which allows it to translocate to the nucleus (35). NF-
ATp dephosphorylation after BCR ligation, as indicated by a
downward shift in molecular weight, was readily apparent in
WT cells but barely detectable in 3BP2/ B cells (Fig. 7C).
3BP2/ B cells responded normally to ionomycin with com-
plete dephosphorylation of NF-ATp. BCR stimulation of
splenic B cells induces NF-AT-dependent upregulation of sur-
face CD5 expression (4, 53). B cells from 3BP2/ mice were
impaired in their ability to upregulate CD5 in response to BCR
ligation (Fig. 7D).
BCR ligation results in the phosphorylation and activa-
tion of the MAP kinases Erk, Jnk, and p38, which are im-
plicated in BCR-mediated proliferation (23, 39). Phosphor-
ylation of ERK1/2 and JNK after BCR ligation was reduced
in 3BP2/ cells, whereas phosphorylation of p38 was un-
affected (Fig. 7E). Phosphorylation of MEK1/2, which is
upstream of ERK, was also decreased after BCR ligation in
3BP2/ B cells (Fig. 8).
BCR ligation also results in phosphatidylinositol 3-kinase
activation and subsequent phosphorylation and activation of
Akt. Akt contributes to NF-B activation, which is important
for B-cell survival (25, 41, 43). Phosphorylation of Akt and of
the NF-B inhibitor IB following BCR ligation was normal in
3BP2/ B cells (Fig. 8).
Serum immunoglobulin levels and serum antibody re-
sponses in 3BP2/mice. Serum levels of IgM, IgG subclasses,
and IgA were not significantly different between 6- and 8-week-
old 3BP2/ mice and WT littermates (data not shown). To
determine the role of 3BP2 in the antibody response, we im-
munized 3BP2/ mice and WT littermates with the T-depen-
dent (TD) antigen TNP-KLH, the type I T-independent (TI)
antigen TNP-LPS, and the type II TI antigen TNP-Ficoll. IgM
and IgG anti-TNP antibody responses of 3BP2/ mice to
all three antigens were comparable to those of WT controls
(Fig. 9A). In addition, 3BP2/ mice made a normal response
to KLH (data not shown). Furthermore, the size and number
of germinal centers in the spleen, as determined by staining for
bcl-6, were comparable in 3BP2/ mice and WT controls
(data not shown).
Activation of B cells by TI antigens, and particularly type II
TI antigens, is dependent on BCR cross-linking and activation
(38). Given their defective BCR signaling, the normal antibody
response of 3BP2/ mice to TI antigens was unexpected.
BCR cross-linking is known to inhibit IgM synthesis and iso-
type switching (26). This raised the possibility that decreased
sensitivity to BCR inhibition of Ig synthesis may compensate
for impaired BCR activation in the antibody response of
3BP2/ mice. To test this hypothesis, we examined the effect
of BCR cross-linking on IgM secretion and isotype switching to
IgG1 and IgE in 3BP2/ B cells. Increasing concentrations of
anti-IgM resulted in a dose-dependent inhibition of IgM se-
cretion and of isotype switching to IgG1 and IgE in LPS/IL-4-
stimulated WT B cells (Fig. 9B). B cells from 3BP2/ mice
secreted significantly more IgM, IgG1, and IgE than B cells
from WT controls in the presence of anti-IgM. At all the
concentrations used, anti-IgM exerted no inhibitory effect on
the proliferation of WT or 3BP2/ B cells to LPS plus IL-4
(data not shown).
FIG. 4. TCR signaling in 3BP2/ mice. Purified splenic T cells were stimulated with anti-CD3 (-CD3; 3 g/ml) and then cross-linked with
10 g/ml goat F(ab)2 anti-rat Ig. (A) Protein tyrosine phosphorylation. pY, phosphotyrosine. (B) Phosphorylation of ZAP-70, Vav1, and PLC-1.
IP, immunoprecipitation. (C) Calcium flux measured as intensity of Fluo-4-AM. Io, ionomycin. (D) MAP kinase phosphorylation.
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DISCUSSION
This study demonstrates that the adapter protein 3BP2 is
important for BCR, but not TCR, signaling.
3BP2-deficient mice were viable and exhibited no apparent
anatomical defects. Hemizygous point mutations of 3BP2 in
humans have been associated with cherubism, which is char-
acterized by multiple symmetric cysts in the jaw bones filled
with multinucleated osteoclasts, stromal cells, and mast cells
(20, 33, 55). All mutations in cherubism are located in exon 9
between the central proline-rich region and C-terminal SH2
domain and affect 3 amino acids within a 6-amino-acid se-
quence. The mutation in cherubism affects only one of the two
3BP2 alleles, and overexpression of the mutant in RBL-2H3
cells inhibits FcεRI-induced mast cell activation (37). Thus, the
mutant gene product may function as a dominant-negative or
gain-of-function mutant, rather than exerting its effect due to
haploinsufficiency. Our observation that the gross and radio-
graphic appearance of the jaws in 3BP2/ and 3BP2/ mice
is normal (our unpublished observations) is consistent with this
hypothesis.
Based on studies using overexpression of 3BP2 and 3BP2
mutants in Jurkat cells, it has been suggested that 3BP2 plays
an important role in TCR-mediated activation (11). Unexpect-
edly, our studies in 3BP2/ mice indicate that 3BP2 is not
essential for either T-cell development or activation via TCR.
T cells from 3BP2/ mice proliferated normally and secreted
normal amounts of IL-2 in response to TCR ligation in vitro
(Fig. 3A to D). Biochemical studies revealed that ZAP-70,
PLC-1, Vav1, and MAP kinases are normally phosphorylated
in 3BP2/ T cells (Fig. 4). Thus, although these three proteins
interact with 3BP2, their phosphorylation after TCR ligation
proceeds in the absence of 3BP2.
3BP2/ mice had a twofold increase in pre-B cells in the
bone marrow (Fig. 2A and Table 1). Signaling via the pre-BCR
is critical for the transition of pre-B cells to immature B cells
and involves signaling pathways similar to those activated by
the BCR (18). Defective signaling via the pre-BCR may have
resulted in the accumulation of pre-B cells in 3BP2/ mice. In
one study, pro-B cells were increased in mice with a disrupted
5 gene, suggesting that pre-BCR signaling also influences
pro-B-cell–to–pre-B-cell transition (29). However, pro-B cells
were normal in 3BP2/ mice.
3BP2/ mice had a twofold increase in splenic T1 B cells
and a twofold decrease in splenic T2 B cells (Fig. 2C), consis-
tent with a role for BCR signaling in the development of T1
cells into T2 cells, as suggested by Syk- and Ig-deficient mice
FIG. 5. B-cell proliferation in 3BP2/ mice. (A to C) Purified splenic B cells from WT mice and 3BP2/ littermates (knockout [KO] mice)
were stimulated with anti-IgM without or with or IL-4 and examined for proliferation as assessed by [3H]thymidine incorporation (A and B) or
CFSE dilution (C). div., divisions. (D) Proliferation of B cells to anti-CD40 and LPS without or with IL-4. Bars represent standard deviation. , P 
0.05.
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(34). B-cell survival in response to BAFF, which is important
for the transition from T1 cells (48), was normal. Although
BCR signaling also plays a role in the maturation of T2 cells
into follicular cells (34), the percentage of follicular cells
was normal in 3BP2/ mice, possibly because recirculating
mature B cells in these mice proliferate normally in re-
sponse to CD40 and Toll receptor engagement and accu-
mulate (Fig. 5D).
An inverse relationship between the strength of BCR sig-
naling and the development of MZ B cells has been suggested
(9). We did not detect a difference in the percentage of IgM
CD21 CD23 MZ B cells in the spleens of 3BP2/ mice.
Low numbers of T2 precursors in 3BP2/ mice may negate
the potentially enhancing effect of weak BCR signaling on the
development of MZ B cells (6). BCR signaling is important for
the generation and maintenance of peritoneal CD5 B1 cells,
as the numbers of these cells are decreased in several gene
knockouts that interfere with BCR signaling (10, 12, 17, 24, 28,
47, 52, 58, 59). Residual BCR signaling in 3BP2/ mice may
be sufficient to sustain the development and maintenance of
normal numbers of CD5 B1 cells in these mice.
B cells from 3BP2/ mice exhibited an activation defect
restricted to BCR ligation. 3BP2-deficient B cells had impaired
proliferation in response to BCR ligation as determined by
[3H]thymidine incorporation and CFSE dilution assay (Fig. 5A
to C). B cells from 3BP2/ mice stimulated via the BCR
failed to upregulate cyclins D2 and D3 and the Cdks Cdk4 and
Cdk6, to degrade the Cdk inhibitor p27, and to phosphorylate
Rb protein (Fig. 6B), all of which are necessary for progression
through the cell cycle. However, phosphorylation of Akt and
IB, which results in activation of NF-B and is important for
B-cell survival (25, 41, 43), was normal in 3BP2/ mice (Fig.
8), consistent with the normal survival of these cells in re-
sponse to BCR ligation (Fig. 6A). Tyrosine phosphorylation of
Syk and its substrate Vav1 following BCR ligation was normal
in 3BP2/ B cells (Fig. 7A). This suggests that activation of
upstream src kinases that phosphorylate Syk is independent of
3BP2. These kinases include Lyn and Fyn, which have been
shown to interact with 3BP2 (11). Tyrosine phosphorylation of
PLC-2, the major isoform of PLC- in B cells, was impaired
in 3BP2/ B cells following BCR ligation (Fig. 7A). PLC-2
phosphorylation following BCR ligation depends on src ki-
nases, Syk, and the Tec kinase Btk (31, 50). It has been shown
that PLC-2 interacts via its SH2 domain with pY183 of 3BP2
(14, 22). The interaction of Syk and 3BP2 involves a phospho-
tyrosine residue in the bridge region of Syk and the SH2
domain of 3BP2 (11), while interaction of the src kinase Lyn
with 3BP2 involves the SH2 and SH3 domains of Lyn with
pY486 and the proline-rich region of 3BP2, respectively (36).
Furthermore, the SH3 domain of the Tec kinase Itk is a can-
didate for interaction with the proline-rich region of 3BP2
(49). This raises the possibility that 3BP2 may serve as a scaf-
fold to promote the phosphorylation of PLC-2 by Syk, src
kinases, and Tec kinases.
Calcium mobilization after BCR ligation was impaired in B
cells from 3BP2/ mice (Fig. 7B). This probably reflects de-
creased activation of PLC-2. More importantly, Ca2/cal-
cineurin-dependent dephosphorylation of the transcription
factor NF-ATp after BCR ligation was impaired in B cells from
3BP2/ mice (Fig. 7C). Furthermore, NF-AT-dependent in-
duction of CD5 expression after BCR ligation was deficient in
these B cells (Fig. 7D). This suggests that 3BP2 is important for
the calcium-dependent activation of NF-AT transcriptional ac-
tivity after BCR ligation. Since NF-AT activation is important
for B-cell proliferation following BCR ligation (3, 56), defec-
tive NF-AT activation probably contributes to impaired pro-
liferation of 3BP2/ B cells in response to anti-IgM.
Activation of the MAP kinase Erk and of its upstream kinase
MEK1/2 after BCR ligation was impaired in B cells from
3BP2/ mice (Fig. 7E and Fig. 8). This is possibly a conse-
quence of impaired PLC-2 activation and decreased genera-
tion of diacylglycerol, which binds to RasGRP and activates
the Ras pathway (13, 40). Since the MEK1/2-Erk pathway is
important for cyclin D2 expression, progression into the cell
cycle and proliferation in response to BCR ligation (42), de-
creased Erk activation following BCR ligation may contribute
to the proliferative defect in 3BP2/ B cells. Decreased phos-
phorylation of Jnk after BCR ligation in 3BP2/ B cells is
compatible with the observations that overexpression of 3BP2
results in the stimulation of AP-1 activity, independently of
NF-AT (11), and that a GCSF-R mutant that fails to bind
3BP2 and Grb2 is impaired in its ability to activate Jnk (27).
In a number of knockouts that selectively disrupt BCR sig-
naling, the antibody response to TD antigens is preserved,
while the antibody response to TI type II antigens is impaired
(16, 19, 24, 28, 57, 59). In some of these knockouts, the total
serum IgG3 level is decreased (28, 59), while in others only the
IgG but not the IgM response to type II TI antigens is affected
(19). Serum Igs were normal in 3BP2/ mice, and these mice
FIG. 6. B-cell survival and progression through the cell cycle. Pu-
rified B cells were stimulated with anti-IgM (-IgM) without or with or
IL-4 or LPS for 24 h. (A) Annexin V and PI staining. Similar results
were obtained at 48 h. (B) Lysates at 36 h were Western blotted for
cyclins D2 and D3, cdk4, cdk6, p27, pRb, and actin as a control.
Results in panels A and B are representative of three experiments.
KO, knockout.
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mounted a normal antibody response and germinal center for-
mation in response to TD antigens (Fig. 9A) (data not shown).
The normal response of these mice to TI antigens (Fig. 9A),
particularly to type II TI antigens, which activate B cells by
cross-linking the BCR, was unexpected. This may be simply
explained by the fact that the BCR signaling defect is incom-
plete in 3BP2/ mice. However, the magnitude of this defect
is comparable to that seen in BLNK/ and Bam32/ mice,
which have impaired antibody response to type II TI antigens
(19, 58). BCR ligation inhibits IgM secretion and isotype
switching in normal B cells (26). We demonstrated that
3BP2/ B cells are less susceptible to the inhibitory effect of
BCR ligation on IgM secretion and isotype switching (Fig. 9B).
The effects of impaired BCR activation and decreased BCR-
mediated inhibition of immunoglobulin production may cancel
out each other in 3BP2/ mice, resulting in a normal antibody
response to TI antigens.
FIG. 7. BCR signaling in 3BP2/ mice. Purified B cells were stimulated with anti-IgM (-IgM). (A) Lysates were immunoprecipitated with
anti-Syk, anti-PLC-2, or anti-Vav1 antibodies and probed with antiphosphotyrosine (pY) MAb 4G10 and reprobed with anti-PLC-2, anti-Syk,
or anti-Vav1 antibodies as loading controls. WB, Western blotting. (B) Calcium mobilization measured as Fluo-4-AM intensity. Io, ionomycin.
(C) NFATp dephosphorylation. deP, dephosphorylation. (D) CD5 surface expression at 72 h. Unst., unstimulated. (E) MAP kinase phosphory-
lation. Lysates were probed with phospho-specific antibodies to ERK1/2, Jnk, and p38. Blots were reprobed with antibodies to Erk1/2, Jnk, and
p38 as loading controls. Results in panels A to E are representative of three experiments. Numbers in panels A and E reflect the relative intensity
of bands representing phosphorylated protein in relation to total protein.
FIG. 8. Phosphorylation of MEK1/2, Akt, and IB in anti-IgM-
stimulated B cells. Purified B cells were stimulated with anti-IgM
(-IgM) at different time points. Lysates were probed with phospho-
specific antibodies to MEK1/2, I	, and Akt, and with antiactin MAb
as a loading control. WB, Western blotting.
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Our results clearly show that 3BP2 is important for BCR
signaling, but redundant for TCR signaling. 3BP2 may be re-
dundant in T cells because of the expression of a functional
homologue. This homologue may not be expressed or may be
poorly expressed in B cells. The observation that TCR signal-
ing is inhibited by overexpression of the isolated SH2 domain
of 3BP2 in Jurkat cells (11) can be explained by inhibition of
the function of both 3BP2 and its homologue. The presence of
a 3BP2 homologue would be consistent with the observation
that 3BP2 sequence was normal in 3 out of 12 families with
cherubism (55).
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